Applied Materials Announces Results for Second Quarter of Fiscal 2007
-
New Orders: $2.65 billion (6% increase year over year; 4%
increase quarter over quarter)
-
Net Sales: $2.53 billion (13% increase year over year; 11%
increase quarter over quarter)
-
Net Income: $411 million (flat year over year; 2% increase
quarter over quarter)
-
EPS: $0.29 ($0.03 increase year over year; flat quarter
over quarter)
SANTA CLARA, Calif.--(BUSINESS WIRE)--Applied Materials, Inc. (Nasdaq:AMAT) reported results for its second
fiscal quarter ended April 29, 2007. Net sales were $2.53 billion, up 13
percent from $2.25 billion for the second quarter of fiscal 2006, and up
11 percent from $2.28 billion for the first quarter of fiscal 2007.
Gross margin for the second quarter of fiscal 2007 was 44.9 percent,
down from 46.5 percent for the second quarter of fiscal 2006, and down
from 46.7 percent for the first quarter of fiscal 2007. Net income for
the second quarter of fiscal 2007 was $411 million, or $0.29 per share,
compared to net income of $413 million, or $0.26 per share, for the
second quarter of fiscal 2006, and compared to net income of $403
million, or $0.29 per share, for the first quarter of fiscal 2007.
Current quarter results reflected charges related to the previously
announced decision to cease development of beamline implant products and
certain charges associated with the acquisition of the software division
of Brooks Automation, Inc.
Non-GAAP net income for the second quarter of fiscal 2007 was $509
million, or $0.36 per share, compared to non-GAAP net income of $457
million, or $0.29 per share, for the second quarter of fiscal 2006.
Non-GAAP net income for the first quarter of fiscal 2007 was $405
million, or $0.29 per share. Non-GAAP adjustments are explained further
below and detailed in the accompanying Reconciliation of GAAP to
non-GAAP Results.
“Applied Materials delivered higher than
expected revenue and earnings this quarter,”
said Mike Splinter, president and CEO. “We
demonstrated our ability to execute across our business lines, deliver
enhanced operational performance and open new opportunities for growth,
announcing our first contracts for solar cell production lines. While
the market for Display remained soft, Silicon and Fab Solutions exceeded
expectations fueled by continued high levels of memory investment and
momentum from market share gains.”
New orders of $2.65 billion for the second quarter of fiscal 2007
increased 6 percent from $2.49 billion for the second quarter of
fiscal 2006, and increased 4 percent from $2.54 billion for the first
quarter of fiscal 2007. Regional distribution of new orders for the
second quarter of fiscal 2007 was: Taiwan 30 percent, North America 15
percent, Korea 15 percent, Southeast Asia and China 15 percent, Japan 14
percent and Europe 11 percent. Backlog at the end of the second quarter
of fiscal 2007 was $3.67 billion, compared to $3.55 billion at the end
of the first quarter of fiscal 2007.
Results by reportable segment for the second quarter of fiscal 2007 were:
|
(In millions)
|
New Orders
|
|
Net Sales
|
|
Operating
Income (loss)
|
|
Silicon
|
$
|
1,939
|
|
$
|
1,738
|
|
$
|
606
|
|
Fab Solutions
|
$
|
559
|
|
$
|
546
|
|
$
|
141
|
|
Display
|
$
|
87
|
|
$
|
203
|
|
$
|
43
|
|
Adjacent Technologies
|
$
|
63
|
|
$
|
43
|
|
$
|
(15)
|
Non-GAAP net income and Non-GAAP EPS, detailed in the accompanying
Reconciliation of GAAP to Non-GAAP Results, exclude charges related to
(i) equity-based compensation, (ii) asset impairment and restructuring
activities, (iii) ceasing development of beamline implant products, (iv)
certain items associated with acquisitions, including amortization of
intangibles, inventory fair value adjustments on products sold and an
in-process research and development charge, and (v) the resolution of
income tax audits and retroactive reinstatement of tax credits.
Management uses non-GAAP net income and non-GAAP EPS to evaluate the
company’s operating and financial performance
in light of business objectives and for planning purposes. These
measures are not in accordance with Generally Accepted Accounting
Principles (GAAP) and may differ from non-GAAP methods of accounting and
reporting used by other companies. Applied believes that these measures
enhance investors’ ability to review the
company’s business from the same perspective
as the company’s management and facilitate
comparisons of this period’s results with
prior periods. The presentation of this additional information should
not be considered a substitute for net income or EPS prepared in
accordance with GAAP.
This press release contains forward-looking statements, including
statements regarding the company’s
performance, growth opportunities, solar business, strategic position
and technology leadership; and the industry outlook. Forward-looking
statements may contain words such as “expect,”
“anticipate,” “believe,”
“may,” “should,”
“will,” “estimate,”
“forecast,” “continue”
or similar expressions, and include the assumptions that underlie such
statements. These statements are subject to known and unknown risks and
uncertainties that could cause actual results to differ materially from
those expressed or implied by such statements. Risks and uncertainties
include, but are not limited to: the sustainability of demand in the
nanomanufacturing technology industry and broadening of demand for
emerging applications such as solar, which are subject to many factors,
including global economic conditions, business and consumer spending,
demand for electronic products and semiconductors, and geopolitical
uncertainties; customers’ capacity
requirements, including capacity utilizing the latest technology, and
fab utilization; the timing, rate, amount and sustainability of capital
spending for new nanomanufacturing technology products; the company’s
ability to (i) successfully develop, deliver and support a broad range
of products and expand its markets and develop new markets, (ii)
maintain effective cost controls and timely align its cost structure
with business conditions, (iii) effectively manage its resources and
production capability, including its supply chain, and (iv) attract,
motivate and retain key employees; the successful implementation and
effectiveness of initiatives to enhance global operations; the
successful integration and performance of acquired businesses; the
effectiveness of joint ventures; and other risks described in Applied
Materials’ Securities and Exchange Commission
filings, including its reports on Forms 10-K, 10-Q and 8-K. All
forward-looking statements are based on management’s
estimates, projections and assumptions as of the date hereof. The
company undertakes no obligation to update any forward-looking
statements.
Applied Materials will discuss its fiscal 2007 second quarter results,
along with its outlook for the third quarter of fiscal 2007, on a
conference call today beginning at 1:30 p.m. Pacific Daylight Time. A
webcast of the conference call will be available on Applied Materials’
web site.
Applied Materials, Inc. (Nasdaq:AMAT) is the global leader in
Nanomanufacturing Technology™ solutions with
a broad portfolio of innovative equipment, services and software
products for the fabrication of semiconductor chips, flat panels, solar
photovoltaic cells, flexible electronics and energy-efficient glass. At
Applied Materials, we apply Nanomanufacturing Technology to improve the
way people live. Learn more at www.appliedmaterials.com.
|
APPLIED MATERIALS, INC.
|
|
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
|
|
April 30,
|
|
April 29,
|
|
April 30,
|
|
April 29,
|
|
(In thousands, except per share amounts)
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
|
Net sales
|
$
|
2,247,686
|
|
$
|
2,529,561
|
|
$
|
4,105,278
|
|
$
|
4,806,828
|
|
Cost of products sold
|
|
1,203,061
|
|
|
1,392,951
|
|
|
2,222,954
|
|
|
2,607,680
|
|
Gross margin
|
|
1,044,625
|
|
|
1,136,610
|
|
|
1,882,324
|
|
|
2,199,148
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
Research, development and engineering
|
|
275,883
|
|
|
291,044
|
|
|
548,760
|
|
|
578,611
|
|
Marketing and selling
|
|
97,706
|
|
|
112,107
|
|
|
198,479
|
|
|
219,019
|
|
General and administrative
|
|
111,543
|
|
|
119,391
|
|
|
216,806
|
|
|
241,202
|
|
Restructuring and asset impairments
|
|
(1,578)
|
|
|
25,044
|
|
|
213,269
|
|
|
21,766
|
|
Income from operations
|
|
561,071
|
|
|
589,024
|
|
|
705,010
|
|
|
1,138,550
|
|
|
|
Pre-tax loss of equity method investment
|
|
--
|
|
|
5,924
|
|
|
--
|
|
|
9,861
|
|
Interest expense
|
|
9,235
|
|
|
8,845
|
|
|
17,940
|
|
|
19,313
|
|
Interest income
|
|
48,630
|
|
|
34,022
|
|
|
97,321
|
|
|
64,125
|
|
Income before income taxes
|
|
600,466
|
|
|
608,277
|
|
|
784,391
|
|
|
1,173,501
|
|
|
|
Provision for income taxes
|
|
187,652
|
|
|
196,833
|
|
|
228,797
|
|
|
358,581
|
|
Net income
|
$
|
412,814
|
|
$
|
411,444
|
|
$
|
555,594
|
|
$
|
814,920
|
|
|
|
Earnings per share:
|
|
|
|
|
|
|
|
|
Basic
|
$
|
0.26
|
|
$
|
0.30
|
|
$
|
0.35
|
|
$
|
0.59
|
|
Diluted
|
$
|
0.26
|
|
$
|
0.29
|
|
$
|
0.35
|
|
$
|
0.58
|
|
|
|
Weighted average number of shares:
|
|
|
|
|
|
|
|
|
Basic
|
|
1,576,548
|
|
|
1,391,076
|
|
|
1,585,577
|
|
|
1,392,477
|
|
Diluted
|
|
1,586,404
|
|
|
1,407,255
|
|
|
1,596,247
|
|
|
1,408,224
|
|
APPLIED MATERIALS, INC.
|
|
CONSOLIDATED CONDENSED BALANCE SHEETS
|
|
|
|
|
October 29,
|
|
April 29,
|
|
(In thousands)
|
2006
|
|
2007
|
|
ASSETS
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
Cash and cash equivalents
|
$
|
861,463
|
|
$
|
932,044
|
|
Short-term investments
|
|
1,035,875
|
|
|
1,085,749
|
|
Accounts receivable, net
|
|
2,026,199
|
|
|
2,121,817
|
|
Inventories
|
|
1,406,777
|
|
|
1,470,601
|
|
Deferred income taxes
|
|
455,473
|
|
|
473,288
|
|
Assets held for sale
|
|
37,211
|
|
|
22,980
|
|
Other current assets
|
|
258,021
|
|
|
252,513
|
|
Total current assets
|
|
6,081,019
|
|
|
6,358,992
|
|
|
|
Long-term investments
|
|
1,314,861
|
|
|
1,349,681
|
|
Property, plant and equipment
|
|
2,753,883
|
|
|
2,730,540
|
|
Less: accumulated depreciation and amortization
|
|
(1,729,589)
|
|
|
(1,700,379)
|
|
Net property, plant and equipment
|
|
1,024,294
|
|
|
1,030,161
|
|
|
|
Goodwill, net
|
|
572,558
|
|
|
652,723
|
|
Purchased technology and other intangible assets, net
|
|
201,066
|
|
|
232,105
|
|
Equity method investment
|
|
144,431
|
|
|
134,570
|
|
Deferred income taxes and other assets
|
|
142,608
|
|
|
137,991
|
|
Total assets
|
$
|
9,480,837
|
|
$
|
9,896,223
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
Current portion of long-term debt
|
$
|
202,535
|
|
$
|
202,535
|
|
Accounts payable and accrued expenses
|
|
2,023,651
|
|
|
2,037,169
|
|
Income taxes payable
|
|
209,859
|
|
|
218,350
|
|
Total current liabilities
|
|
2,436,045
|
|
|
2,458,054
|
|
|
|
Long-term debt
|
|
204,708
|
|
|
204,341
|
|
Other liabilities
|
|
188,684
|
|
|
196,088
|
|
Total liabilities
|
|
2,829,437
|
|
|
2,858,483
|
|
|
|
Stockholders' equity:
|
|
|
|
|
Common stock
|
|
13,917
|
|
|
13,820
|
|
Additional paid-in capital
|
|
3,678,202
|
|
|
3,876,262
|
|
Retained earnings
|
|
9,472,303
|
|
|
10,134,422
|
|
Treasury stock
|
|
(6,494,012)
|
|
|
(6,975,290)
|
|
Accumulated other comprehensive loss
|
|
(19,010)
|
|
|
(11,474)
|
|
Total stockholders' equity
|
|
6,651,400
|
|
|
7,037,740
|
|
Total liabilities and stockholders' equity
|
$
|
9,480,837
|
|
$
|
9,896,223
|
|
APPLIED MATERIALS, INC.
|
|
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
|
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
|
|
|
April
30,
|
|
January
28,
|
|
April
29,
|
|
April
30,
|
|
April
29,
|
|
(In thousands, except per share amounts)
|
|
2006
|
|
2007
|
|
2007
|
|
2006
|
|
2007
|
|
Non-GAAP Net Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported net income (GAAP basis)
|
$
|
412,814
|
|
$
|
403,476
|
|
$
|
411,444
|
|
$
|
555,594
|
|
$
|
814,920
|
|
Equity-based compensation expense
|
|
55,080
|
|
|
34,900
|
|
|
47,922
|
|
|
107,032
|
|
|
82,822
|
|
Restructuring and asset impairments 1, 2
|
|
(1,578)
|
|
|
(3,278)
|
|
|
25,044
|
|
|
213,269
|
|
|
21,766
|
|
Costs associated with ceasing development of beamline implant
products 3
|
|
-
|
|
|
-
|
|
|
50,299
|
|
|
-
|
|
|
50,299
|
|
Certain items associated with acquisitions 4
|
|
5,340
|
|
|
13,380
|
|
|
23,725
|
|
|
11,199
|
|
|
37,105
|
|
Resolution of audits of prior years' income tax filings and
credits 5
|
|
-
|
|
|
(29,863)
|
|
|
-
|
|
|
-
|
|
|
(29,863)
|
|
Income tax effect of non-GAAP adjustments
|
|
(14,956)
|
|
|
(13,434)
|
|
|
(49,239)
|
|
|
(114,575)
|
|
|
(62,673)
|
|
|
|
Non-GAAP net income
|
$
|
456,700
|
|
$
|
405,181
|
|
$
|
509,195
|
|
$
|
772,519
|
|
$
|
914,376
|
|
|
|
Non-GAAP Net Income Per Diluted
Share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported net income per diluted share (GAAP basis)
|
$
|
0.26
|
|
$
|
0.29
|
|
$
|
0.29
|
|
$
|
0.35
|
|
$
|
0.58
|
|
Equity-based compensation expense
|
|
0.03
|
|
|
0.02
|
|
|
0.02
|
|
|
0.05
|
|
|
0.04
|
|
Restructuring and asset impairments
|
|
-
|
|
-
|
|
|
0.01
|
|
|
0.08
|
|
|
0.01
|
|
Costs associated with ceasing development of beamline implant
products
|
|
-
|
|
|
-
|
|
|
0.02
|
|
|
-
|
|
0.02
|
|
Certain items associated with acquisitions
|
|
-
|
|
|
0.01
|
|
|
0.01
|
|
|
-
|
|
0.02
|
|
Resolution of audits of prior years' income tax filings and credits
|
|
-
|
|
|
(0.02)
|
|
|
-
|
|
|
-
|
|
|
(0.02)
|
|
|
|
Non-GAAP net income - per diluted share
|
$
|
0.29
|
|
$
|
0.29
|
|
$
|
0.36
|
|
$
|
0.48
|
|
$
|
0.65
|
|
|
|
Shares used in diluted shares calculation
|
|
1,586,404
|
|
1,409,014
|
|
1,407,255
|
|
1,596,247
|
|
1,408,224
|
|
|
|
1 Results for the six months ended April
30, 2006 included asset impairment and restructuring charges of
$213 million associated primarily with the facilities
disinvestment program. Results for the three months ended January
28, 2007 included a net benefit of $4 million from the sale of the
Hillsboro, Oregon facility. Results for the three months ended
April 29, 2007 included a slight benefit from the sale of the
Chunan, Korea facility.
|
|
|
|
2 Results for the three and six months
ended April 29, 2007 included restructuring and asset impairment
charges of $25 million associated with ceasing development of
beamline implant products.
|
|
|
|
3 Results for the three and six months
ended April 29, 2007 included other operating charges of $50
million associated with ceasing development of beamline implant
products.
|
|
|
|
4 Incremental charges attributable to
acquisitions consisted of inventory fair value adjustments on
products sold and amortization of purchased intangible assets.
Results for the three and six months ended April 29, 2007 included
an in-process research and development charge of $5 million
associated with the acquisition of the software division of Brooks
Automation, Inc. in the second fiscal quarter of 2007.
|
|
|
|
5 Consists of a $24 million benefit from
the resolution of audits of prior years' income tax filings and a
$6 million benefit related to the retroactive reinstatement to
January 1, 2006 of the research and development tax credit
pursuant to the Tax Relief and Health Care Act of 2006.
|
Permalink: http://www.businesswire.com/news/appliedmaterials/20070515006435/en
|
|